Law360, New York (March 03, 2010, 4:48 PM ET) -- Boehringer Ingelheim Corp. is seeking to split up for trial certain claims against it in a case alleging it defrauded Medicare and Medicaid programs by reporting inflated drug prices.
Boehringer and sister company Boehringer Ingelheim Pharmaceuticals Inc. on Monday asked the U.S. District Court for the District of Massachusetts, which is overseeing consolidated multidistrict litigation brought by the U.S. government and relator Ven-A-Care of the Florida Keys Inc., to bifurcate certain corporate veil-piercing claims against them from underlying False Claims Act allegations against them and unit...
Boehringer Seeks To Divide Claims In AWP Case
To view the full article, take a free trial now.
